{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:38:06Z","timestamp":1784734686831,"version":"3.55.0"},"reference-count":114,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T00:00:00Z","timestamp":1481241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA 031718"],"award-info":[{"award-number":["R01 DA 031718"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:p>Substance use disorders are diagnosed as a manifestation of inappropriate behavioral allocation toward abused drugs and away from other behaviors maintained by more adaptive nondrug reinforcers (e.g., money and social relationships). Substance use disorder treatment goals include not only decreasing drug\u2010maintained behavior but also promoting behavioral reallocation toward these socially adaptive alternative reinforcers. Preclinical drug self\u2010administration procedures that offer concurrent access to both drug and nondrug reinforcers provide a translationally relevant dependent measure of behavioral allocation that may be useful for candidate medication evaluation. In contrast to other abused drugs, such as heroin or cocaine, preclinical methamphetamine versus food choice procedures have been a more recent development. We hypothesize that preclinical to clinical translatability would be improved by the evaluation of repeated pharmacological treatment effects on methamphetamine self\u2010administration under a methamphetamine versus food choice procedure. In support of this hypothesis, a literature review suggests strong concordance between preclinical pharmacological treatment effects on methamphetamine versus food choice in nonhuman primates and clinical medication treatment effects on methamphetamine self\u2010administration in human laboratory studies or methamphetamine abuse metrics in clinical trials. In conclusion, this literature suggests preclinical methamphetamine versus food choice procedures may be useful in developing innovative pharmacotherapies for methamphetamine use disorder.<\/jats:p>","DOI":"10.1111\/nyas.13276","type":"journal-article","created":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T04:36:28Z","timestamp":1481344588000},"page":"92-105","source":"Crossref","is-referenced-by-count":15,"title":["Utility of preclinical drug versus food choice procedures to evaluate candidate medications for methamphetamine use disorder"],"prefix":"10.1111","volume":"1394","author":[{"given":"Matthew L.","family":"Banks","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology Virginia Commonwealth University Richmond Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,12,9]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2012.02145.x"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10652"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.14.5274"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.304"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb04182.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199108000-00017"},{"key":"e_1_2_7_9_1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-3565(25)29645-8","article-title":"Self\u2010administration of optical isomers of amphetamine and methylamphetamin by rats","volume":"187","author":"Yokel R.A.","year":"1973","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00421107"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00405254"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(73)90057-9"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130100738"},{"key":"e_1_2_7_14_1","unstructured":"UNODC.2015.World drug report 2015.United Nations Office on Drugs and Crime Vienna."},{"key":"e_1_2_7_15_1","unstructured":"DEA.2015.National Forensic Laboratory Information System: 2014 annual report. Department of Justice Drug Enforcement Administration Springfield VA."},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12048"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-008-1079-x"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.03.001"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40501-015-0042-9"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a012104"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv009"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.011668"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0893-133X(95)00274-H"},{"key":"e_1_2_7_24_1","first-page":"281768","article-title":"Preclinical determinants of drug choice under concurrent schedules of drug self\u2010administration","volume":"2012","author":"Banks M.L.","year":"2012","journal-title":"Adv. Pharmacol. Sci"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1124\/mi.6.5.9"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.2307\/j.ctvjf9xd9"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2010.04.005"},{"key":"e_1_2_7_28_1","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnositc and Statistical Manual of Mental Disorders","author":"American Pyschiatric Association","year":"2013"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.02014.x"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.05.022"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.05.021"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2015.03.023"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1901\/jeab.1984.41-35"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0b013e32830990bf"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(81)90088-0"},{"key":"e_1_2_7_36_1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0031-6997(25)06689-X","article-title":"Discrete\u2010trial choice procedure: effects of naloxone and methadone on choice between food and heroin","volume":"27","author":"Griffiths R.R.","year":"1975","journal-title":"Pharmacol. Rev"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(77)90248-9"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12220"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1966.00290160004002"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12051"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728214.2014.899580"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01728.x"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.307"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02717.x"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2001.96912898.x"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000207"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.08.022"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pbr.2015.07.012"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1990.tb136930.x"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00052-0"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.113.208264"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1037\/a0022432"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050836"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2006.08.004"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.114.009514"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.01.036"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2012.10.275"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12636"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301481"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.03.010"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.11.023"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.07.007"},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02437.x"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2014.11.018"},{"key":"e_1_2_7_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.08.013"},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12109"},{"key":"e_1_2_7_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12608"},{"key":"e_1_2_7_68_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.1.160"},{"key":"e_1_2_7_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2015.63"},{"key":"e_1_2_7_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2008.02.002"},{"key":"e_1_2_7_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.09.006"},{"key":"e_1_2_7_72_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145711000988"},{"key":"e_1_2_7_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb06688.x"},{"key":"e_1_2_7_74_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2002.10399967"},{"key":"e_1_2_7_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.03.019"},{"key":"e_1_2_7_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(96)00154-7"},{"key":"e_1_2_7_77_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v13n04_08"},{"key":"e_1_2_7_78_1","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0b013e32834d63ac"},{"key":"e_1_2_7_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.10.016"},{"key":"e_1_2_7_80_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.3.377"},{"key":"e_1_2_7_81_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-23-09414.2001"},{"key":"e_1_2_7_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2015.07.035"},{"key":"e_1_2_7_83_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.8.1206"},{"key":"e_1_2_7_84_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.16.8.1285"},{"key":"e_1_2_7_85_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.2.210"},{"key":"e_1_2_7_86_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.095380"},{"key":"e_1_2_7_87_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M805298200"},{"key":"e_1_2_7_88_1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0022-3565(24)37511-1","article-title":"Drug discrimination in methamphetamine\u2010trained monkeys: agonist and antagonist effects of dopaminergic drugs","volume":"285","author":"Tidey J.W.","year":"1998","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"e_1_2_7_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2009.06.004"},{"key":"e_1_2_7_90_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2007.10399875"},{"key":"e_1_2_7_91_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e31818e2185"},{"key":"e_1_2_7_92_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0808"},{"key":"e_1_2_7_93_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13r08525"},{"key":"e_1_2_7_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2014.12.024"},{"key":"e_1_2_7_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2010.00211.x"},{"key":"e_1_2_7_96_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109358201"},{"key":"e_1_2_7_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2011.02.046"},{"key":"e_1_2_7_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12073"},{"key":"e_1_2_7_99_1","doi-asserted-by":"publisher","DOI":"10.3109\/13651501.2012.667116"},{"key":"e_1_2_7_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2013.08.007"},{"key":"e_1_2_7_101_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301353"},{"key":"e_1_2_7_102_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-014-3760-6"},{"key":"e_1_2_7_103_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.12.2015"},{"key":"e_1_2_7_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0270(96)00010-6"},{"key":"e_1_2_7_105_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4000760"},{"key":"e_1_2_7_106_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3182983ffa"},{"key":"e_1_2_7_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2006.06.002"},{"key":"e_1_2_7_108_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145707007778"},{"key":"e_1_2_7_109_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2004.02714.x"},{"key":"e_1_2_7_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(01)00333-5"},{"key":"e_1_2_7_111_1","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12045"},{"key":"e_1_2_7_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62106-6"},{"key":"e_1_2_7_113_1","unstructured":"Walsh S.2016.FDA approves first drug to treat hallucinations and delusions associated with Parkinson's disease. Accessed October 5 2015.http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm498442.htm."},{"key":"e_1_2_7_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.05.014"},{"key":"e_1_2_7_115_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12709"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fnyas.13276","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fnyas.13276","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/nyas.13276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T12:18:01Z","timestamp":1749817081000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/nyas.13276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,9]]},"references-count":114,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1111\/nyas.13276"],"URL":"https:\/\/doi.org\/10.1111\/nyas.13276","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,9]]}}}